stella
beta
A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation — Stella
Home
/
Healthy
/
View on ClinicalTrials.gov
Recruiting
Back to Healthy trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Canada
University of Ottawa Heart Institute, Ottawa, Ontario